Stories By HEALTH BROADCASTING SERVICE®
-
HBS Reporting
Bluebird Bio’s gene therapy for neurological disorder gets FDA panel backing
Jun 15, 2022June 9 (Reuters) – Advisers to the U.S. Food and Drug Administration on Thursday voted to...
-
HBS Reporting
UK says Mariupol at risk of cholera outbreak
Jun 15, 2022June 10 (Reuters) – Ukraine’s southern city of Mariupol is at risk of a major cholera...
-
HBS Reporting
Sanofi’s Dupixent gets U.S. approval to treat eczema in young children
Jun 9, 2022June 7 (Reuters) – The U.S. Food and Drug Administration approved the use of Sanofi (SASY.PA)...
-
HBS Reporting
Moderna says Omicron-targeted COVID shot shows better response
Jun 9, 2022June 8 (Reuters) – Moderna Inc (MRNA.O) said on Wednesday a new version of its coronavirus...
-
HBS Reporting
COVID vaccine rights waiver within reach, WTO chief says ahead of meeting
Jun 9, 2022GENEVA, June 8 (Reuters) – An international agreement on waiving intellectual property rights for COVID-19 vaccines...
-
HBS Reporting
‘Widen gaze from Ukraine’ to avert famine in Somalia, U.N. agency warns
Jun 8, 2022LONDON, June 7 (Reuters) – The world must “widen its gaze from the war in Ukraine”...